Plaintiffs and friends urge First Circuit to keep Nexium class together

Harry Phillips

27 June 2014

AstraZeneca holds the patent to Nexium, a gastointestinal drug

Subscribe to Global Competition Review

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

View full biography

Author

[email protected]

Like fine wine: The Tipline for 31 March 2023
The Robinson-Patman Act never died. A generation of antitrust enforcers have been ageing the law passed three years after the end of Prohibition in barrels deep beneath the Federal Trade Commission. Agency chair Lina Khan et al are now ready to uncork it. Politico reports the FTC is probing whether Southern Glazer’s Wine and Spirits has been unfairly favouring larger retailers. Also in Tipline, Senator Mike Lee brings back legislation that could break up …
With great power comes great document discovery: The Tipline for 30 March 2023
Wins and losses: The Tipline for 29 March 2023